Cell-surface proteomics for the identification of novel therapeutic targets in cancer
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Cancer is the second most common cause of death worldwide and its heterogeneity complicates therapy. Standard cytotoxic regiments disrupt rapidly dividing cells, regardless of their neoplastic status. The introduction of less toxic targeted therapies has partially contributed to the observed decrease in cancer-related mortality. Cell-surface proteins represent attractive targets for therapy, due to their easily-accessible localization and their involvement in essential signaling pathways, often dysregulated in cancer. Despite their clinical appeal, cell-surface proteins are often underrepresented in standard proteomic data sets, due to their poor solubility and lower expression levels compared to intracellular proteins. Areas covered: This review will summarize some of the available techniques for enriching the cell-surface proteome, and discuss their advantages, limitations and applicability to clinical sample-testing. Moreover, we discuss currently available strategies for the development of novel targeted therapies in cancer. Expert commentary: The interest in elucidating the cancer-associated surfaceome is growing and will likely benefit from recent advancements in instrument sensitivity, method development, and a growing body of high-quality proteomics databases. Multiomics studies, in combination with functional validations (e.g. dropout screens), and evaluation of the healthy surfaceome, will likely aid in the selection of relevant targets for future therapy development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Universal sample preparation method for proteome analysis
Wiśniewski, J. R., Zougman, A., Nagaraj, N., & Mann, M. (2009) · Nature Methods · doi:10.1038/nmeth.1322 · Cited by 8,352
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893 · cited 2×
“replication [3,4], remain the most common treatment options.”
BackgroundCetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, E., Köhne, C.-H., Hitre, E., Zaluski, J., Chang Chien, C.-R., Makhson, A., D'Haens, G., Pintér, T., Lim, R., Bodoky, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805019 · Cited by 3,877
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Gillet, L. C., Navarro, P., Tate, S., Röst, H., Selevsek, N., Reiter, L., Bonner, R., & Aebersold, R. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o111.016717 · Cited by 2,877
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Peterson, A. C., Russell, J. D., Bailey, D. J., Westphall, M. S., & Coon, J. J. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.020131 · Cited by 1,288
Global signatures of protein and mRNA expression levels
de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M., & Vogel, C. (2009) · Molecular BioSystems · doi:10.1039/b908315d · Cited by 1,248
Research works printed but not linked: 133
- 10.1016/j.cell.2011.02.013 · DOI · Paper page
- 10.1038/550431a · doi:10.1038/550431a
- 10.1111/joim.12708 · DOI · Paper page
- 10.1083/jcb.201202014 · DOI · Paper page
- 10.1038/nm.2344 · DOI · Paper page
- 10.1016/j.molonc.2010.04.004 · DOI · Paper page
- 10.1200/JCO.2013.54.2258 · DOI · Paper page
- Balduzzi S, 2014, Cochrane Database Syst Rev, 6, CD006242
- 10.1007/s11523-013-0258-9 · DOI
- Wiggans AJ, 2015, Cochrane Database Syst Rev, 5, CD007929
- 10.3322/caac.21332 · DOI · Paper page
- 10.1021/acs.jmedchem.5b00457 · DOI · Paper page
- 10.1038/nm.4038 · DOI · Paper page
- 10.1016/j.clbc.2016.05.012 · DOI · Paper page
- 10.1038/nrc.2017.84 · DOI · Paper page
- 10.1002/pmic.201300264 · DOI
- 10.1158/0008-5472.CAN-08-0999 · doi:10.1158/0008-5472.can-08-0999
- 10.21037/atm.2016.12.26 · DOI
- 10.15252/emmm.201302627 · DOI · Paper page
- 10.1002/pmic.201200340 · DOI
- 10.1038/nbt0303-262 · DOI · Paper page
- 10.1586/epr.09.97 · DOI
- 10.1002/prca.200780122 · DOI
- 10.1021/pr0502370 · DOI
- 10.1186/s13073-017-0454-9 · DOI
- 10.1097/MPA.0b013e3182236385 · doi:10.1097/mpa.0b013e3182236385
- 10.1039/b708581h · DOI
- 10.1016/j.jprot.2008.09.003 · DOI
- 10.1038/nprot.2006.359 · DOI
- 10.1007/978-1-61779-139-0_16 · DOI
- 10.1038/nbt819 · DOI · Paper page
- 10.1002/pmic.201000308 · DOI
- 10.1038/nprot.2006.29 · DOI
- 10.1016/j.devcel.2012.01.005 · DOI
- 10.3791/51349 · doi:10.3791/51349
- 10.1038/s41467-017-00561-0 · DOI · Paper page
- 10.1371/journal.pone.0121314 · DOI · Paper page
- 10.1038/nmeth.1305 · DOI · Paper page
- 10.1021/acs.jproteome.5b01066 · DOI
- 10.1080/15384047.2015.1071740 · DOI
- 10.1002/anie.201701424 · DOI
- 10.1002/pmic.200600579 · DOI
- 10.1002/pmic.200300492 · DOI
- 10.1007/s00216-012-5832-y · DOI
- 10.1161/01.RES.0000071748.48338.25 · DOI · Paper page
- 10.1002/pmic.200401048 · DOI · Paper page
- Hogeboom GH, 1948, J Biol Chem, 172, 619, 10.1016/S0021-9258(19)52749-1 · DOI · Paper page
- Deduve C, 1959, Prog Biophys Mol Bio, 9, 325
- 10.1002/pmic.200800597 · DOI · Paper page
- 10.18632/oncotarget.13566 · DOI
- 10.1016/j.tibs.2013.12.004 · DOI · Paper page
- Chaney LK, 1983, J Biol Chem, 258, 10062, 10.1016/S0021-9258(17)44606-0 · DOI · Paper page
- 10.1038/nbt993 · DOI · Paper page
- 10.1074/mcp.M111.012526 · DOI
- 10.1007/s12013-009-9045-8 · doi:10.1007/s12013-009-9045-8
- 10.1038/ncomms9391 · DOI
- 10.1021/pr800986c · DOI
- 10.1002/pmic.200800120 · DOI
- 10.1002/pmic.201000808 · DOI
- 10.1586/era.10.226 · DOI · Paper page
- 10.1002/pmic.200800097 · DOI · Paper page
- 10.1016/j.jprot.2016.04.014 · DOI
- 10.1016/0303-2647(94)90039-6 · doi:10.1016/0303-2647(94)90039-6
- 10.1038/nrm954 · DOI · Paper page
- 10.1021/ja066950n · DOI · Paper page
- 10.1097/MPA.0000000000000743 · DOI
- 10.3945/jn.108.091967 · doi:10.3945/jn.108.091967
- 10.1038/nrc1627 · DOI · Paper page
- Ahlskog J, 2006, Q J Nucl Med Mol Imaging, 50, 296
- 10.1182/blood-2009-08-239004 · DOI
- 10.1007/s00432-012-1327-7 · DOI
- 10.1074/mcp.M600164-MCP200 · DOI
- 10.1002/pmic.201200414 · DOI
- 10.1016/S0304-4165(99)00165-8 · DOI · Paper page
- 10.1007/978-1-62703-146-2_3 · DOI
- Greg H, 2008, Bioconjugate techniques
- 10.1016/0076-6879(94)30006-2 · DOI · Paper page
- 10.1093/glycob/cwn069 · doi:10.1093/glycob/cwn069
- 10.1074/mcp.M116.063859 · DOI
- 10.1093/bioinformatics/btt607 · DOI · Paper page
- 10.1021/pr300360a · DOI
- 10.1073/pnas.1701263114 · DOI
- 10.1021/acs.jproteome.6b00470 · DOI
- de Sousa Abreu R, 2009, Mol Biosyst, 5, 1512
- 10.1038/nrc3982 · DOI · Paper page
- 10.1021/pr500880b · DOI · Paper page
- 10.1021/pr9009113 · DOI
- 10.1074/mcp.M111.015362 · DOI · Paper page
- 10.1038/nmeth.2291 · DOI
- 10.1038/nmeth.2309 · DOI · Paper page
- 10.1586/14737159.2013.845089 · DOI · Paper page
- 10.12688/f1000research.7042.1 · DOI · Paper page
- 10.2174/1389201003379059 · DOI · Paper page
- Graziano C, 1998, CAP Today, 12, 1, 14
- 10.1080/19420862.2016.1269580 · DOI · Paper page
- 10.1111/cei.13081 · DOI · Paper page
- 10.1097/PAI.0000000000000575 · DOI · Paper page
- 10.4161/mabs.2.2.11360 · DOI · Paper page
- 10.1186/gm529 · DOI
- 10.1038/nrd.2017.227 · DOI · Paper page
- 10.1016/j.clml.2016.01.004 · DOI
- 10.1021/pr200212r · DOI
- 10.1634/stemcells.2008-0397 · DOI
- 10.1038/nprot.2013.072 · DOI
- 10.1146/annurev-immunol-051116-052433 · DOI · Paper page
- 10.1158/0008-5472.CAN-16-2774 · DOI · Paper page
- 10.1186/1479-5876-11-307 · DOI · Paper page
- Bakema JE, 2014, Curr Top Microbiol Immunol, 382, 373
- 10.1080/10428194.2017.1281411 · DOI
- 10.1016/j.drudis.2017.05.011 · DOI · Paper page
- 10.1038/leu.2017.187 · DOI · Paper page
- 10.1038/nbt1011-851 · doi:10.1038/nbt1011-851
- 10.2146/news130023 · doi:10.2146/news130023
- Lamb YN, Drugs
- 10.1016/j.critrevonc.2016.07.008 · DOI
- 10.1208/s12248-015-9766-0 · DOI
- 10.7150/jca.2.309 · DOI
- 10.1038/icb.2014.93 · DOI · Paper page
- 10.1093/intimm/dxu089 · DOI
- 10.1016/j.tips.2016.10.005 · DOI · Paper page
- 10.1146/annurev-pharmtox-010611-134654 · DOI · Paper page
- 10.1016/j.it.2015.06.004 · DOI · Paper page
- 10.1111/imr.12126 · DOI
- 10.18632/oncotarget.5582 · DOI · Paper page
- 10.1111/sji.12331 · DOI
- 10.1016/j.coi.2015.01.002 · DOI · Paper page
- 10.1371/journal.pone.0094281 · DOI · Paper page
- 10.4049/jimmunol.1402346 · DOI · Paper page
- 10.1001/jama.2017.15218 · DOI · Paper page
- 10.1080/10428194.2017.1387905 · DOI · Paper page
- Grover N, 2016, Reuters
- 10.1016/j.beha.2017.09.002 · DOI
- 10.1016/j.phrs.2017.11.035 · DOI
Cited by
Basisty, N., Kale, A., Patel, S., Campisi, J., & Schilling, B. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1766976 · Cited by 69
Defining the Cell Surface Cysteinome Using Two-Step Enrichment Proteomics
(2023) · doi:10.1021/jacsau.3c00707 · Cited by 21
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma
Raymond, J. H., Aktary, Z., Larue, L., & Delmas, V. (2022) · Cancers · doi:10.3390/cancers14030706 · Cited by 20
Metadata
- Authors
- Kuhlmann, L., Cummins, E., Samudio, I., & Kislinger, T.
- Venue
- Expert Review of Proteomics
- Publisher
- Informa UK Limited
- Published
- 2018-01-23
- Volume
- 15
- Issue
- 3
- Pages
- 259-275
- ISSN
- 1478-9450 (ISSN-L)
- 1744-8387
- OpenAlex
- W2793864521
- Cited by
- 81
- References
- 21
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Ontario Ministry of Health and Long-Term Care
- Canadian Cancer Society Research Institute (703777)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell-surface proteomics for the identification of novel therapeutic targets in cancer. https://app.cochat.ai/papers/10.1080/14789450.2018.1429924
- The paper
- Kuhlmann, L., Cummins, E., Samudio, I., & Kislinger, T. (2018). Cell-surface proteomics for the identification of novel therapeutic targets in cancer. Expert Review of Proteomics. https://doi.org/10.1080/14789450.2018.1429924
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.